Print ACNR MJ05 v4 - Advances in Clinical Neuroscience and ...

News ReviewNew Leaflet Addresses Key Questions aboutBotulinum Toxin‘Botulinum toxin: yourquestions answered’ is anew leaflet for peoplewith dystonias availablefrom Ipsen Limited. Theleaflet was developed initiallyto help The DystoniaSociety, the organisationdedicated to the supportof people affected by dystonia,answer questionsfrom members about theuse of botulinum toxintype A (Dysport ® ).Dystonia is a term usedto describe a group ofconditions characterised by uncontrollablemuscle spasms that can affect oneor several parts of the body, causingabnormal movements and postures. Thecondition is thought to affect over40,000 people in the UK, making it tentimes more common than motor neuronedisease. It is estimated that therecould be thousands more dystonia sufferers,many of whomdo not realise that theyhave the condition.Dysport® is not a newmedicine for the treatmentof dystonia – ithas been used successfullyfor over 15 years.The leaflet addressesa wide range of questionsranging from ‘howdoes it work?’ to ‘do Ihave to come to hospitalfor my treatment?’and ‘how many injectionswill I need?’. Thequestions are answered simply and concisely.Copies of the leaflet can be obtainedfrom Medical Information Department,Ipsen Ltd, 190 Bath Road, Slough,Berkshire, SL1 3XE.Tel: 01753 627777,Email: medical.information.uk@ipsen.comNew Sonara Digital Transcranial Doppler SystemPulse Medical Limited have introducedthe Sonara digitalTranscranial Doppler system fromBiobeat Medical, available with 2,4, 8Mhz probes and monitoringHead-frame.Operating the Sonara is simpleand intuitive with its large 15”integrated touch screen display.The user-friendly remote controlcan be used in one hand to controlall of the main features.The Sonara has many featuresincluding M-Mode display,Monitoring, Multi-gating, VelocityProfiles, Emboli Detection, and manyunique features such as SummaryScreen, Risk factor and Trends.The Sonara is also ideal for researchwith complete statistical analysis of yourpatient database, with colourful graphs.The data can even be exported as a Bmp,Excel format, or as raw data.For further information please contactPulse Medical Limited, 3000 CathedralHill, Guildford, Surrey GU2 7YB.Tel: 01483 243573Fax: 01483 243501.Email: sales@pulsemedical.co.ukWeb: www.pulsemedical.co.ukBotulinum Toxin in the Treatmentof Cerebral Palsy‘The role of botulinumtoxin in thetreatment of cerebralpalsy. Frequentlyasked questions andanswers for parentsand children’ is anew booklet availablefrom IpsenLimited. The bookletwas developedtogether with Scope,the disability organisationin Englandand Wales.Cerebral palsy iscaused by damage to the brain that takes place before,during or in the early days after birth. When the brain isdamaged in this way, many children have ‘spasticity’,where their arms and legs feel stiff and are difficult tomove. Some movement may be possible, but tends tobe quite limited and prevents them from independentlyjoining many of the activities in which children participate.Botulinum toxin type A (Dysport ® ) can be used totreat this spasticity in children of two years of age andolder.The booklet will help parents and children understandwhy botulinum toxin injections have been recommended.It explains what botulinum toxin is, how it is used,how it works and what effects it has. At the end of thebooklet there are some frequently asked questions.Copies of the leaflet can be obtained from MedicalInformation Department, Ipsen Ltd, 190 Bath Road,Slough, Berkshire, SL1 3XE. Tel: 01753 627777.Email: medical.information.uk@ipsen.com and fromScope’s website: www.scope.org.ukAnnual National DementiaConferenceMA Healthcare are once again staging their AnnualNational Dementia Conference. Held on the 23-24February 2006 in London, this conference attracts keyspeakers within the field of dementia and delegates fromaround the UK. Now in its 8th year places at this fullyCPD accredited conference sell out quickly so secureyour place today by going online at www.mahealthcareevents.co.uk,or by calling the booking hotline on01425 481464.Free SpO2 Pulse Oximeter Sensor Audit from the ElectrodeCompany38 I ACNR • VOLUME 5 NUMBER 6 • JANUARY/FEBRUARY 2006The Electrode Company Ltd specialises in non-invasivemonitoring, optical sensors and high performancepulse oximetry. It produces a portable microspectrometer,which, in an independent UK wide survey of pulseoximeter sensor accuracy in over 30 hospitals discoveredthat over 30% were a cause for concern.To help hospitals establish their own quality control,the company is offering a free audit to test up to 50SpO2 sensors in individual NHS Trusts; this offer isavailable now and up to March 31st 2006. Theresults of each individual trial will be sent in a confidentialwritten report to each Trust.The use of pulse oximeters is becoming more widespread,and increasingly patients are being SpO2monitored intermittently on the wards. Their accuracyis important because it has clinical ramifications iffaulty. For example, a sensor with a positive error willlead clinicians to believe that the patient is better oxygenatedthan is the case.For information on this free audit, please contactthe Electrode Company on audit@electro.co.uk orTel. 01633 861772.